What is SenesTech?
Founded in 2004, SenesTech operates within the biotechnology sector, specializing in reproductive physiology to offer humane animal population management. The company has pioneered a novel approach to pest control by utilizing fertility management, with its flagship product designed to be safe for non-target species, humans, and the environment. This innovative strategy positions SenesTech as a leader in sustainable pest control solutions, moving beyond traditional methods.
How much funding has SenesTech raised?
SenesTech has raised a total of $15.3M across 2 funding rounds:
Stock Offering
$15M
Debt
$350K
Stock Issuance/Offering (2016): $15M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Key Investors in SenesTech
PPP
Public-Private Partnership
What's next for SenesTech?
The recent major strategic investment in SenesTech suggests the company is entering a growth phase, likely focused on expanding market reach and further developing its product pipeline. This enterprise-level backing indicates confidence from investors in SenesTech's unique approach to pest management and its potential for significant impact. Future endeavors may include broader commercialization efforts, strategic partnerships, and continued research into reproductive physiology applications for animal control.
See full SenesTech company page
